Cognition Therapeutics
CGTX · NASDAQ
$0.7338+$0.0064 (+0.88%)TodayMarket closed ·
Prev close $0.7274
Who owns CGTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 21.3% of CGTX’s shares.
- Bios Equity Partners, LP.6.7%
- Davenport Asset Management4.8%
- Vanguard Capital Management, LLC3.8%
- BlackRock Institutional Trust Company, N.A.1.4%
- Next 6 largest institutions4.6%
- All other shareholders78.7%
| Holder | Shares | % of shares |
|---|---|---|
| Bios Equity Partners, LP. | 6.00M | 6.70% |
| Davenport Asset Management | 4.26M | 4.76% |
| Vanguard Capital Management, LLC | 3.44M | 3.84% |
| BlackRock Institutional Trust Company, N.A. | 1.24M | 1.39% |
| Chescapmanager, L.L.C. | 997.03K | 1.11% |
| Geode Capital Management, L.L.C. | 910.01K | 1.02% |
| Renaissance Technologies LLC | 693.29K | 0.77% |
| Hilton Capital Management, LLC | 548.95K | 0.61% |
| Vanguard Fiduciary Trust Co | 508.22K | 0.57% |
| CM Management, LLC | 450.00K | 0.50% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44M | 2.73% |
| Vanguard Extended Market Index Fund | 923.90K | 1.03% |
| Fidelity Extended Market Index Fund | 418.88K | 0.47% |
| iShares Micro-Cap ETF | 278.86K | 0.31% |
| Fidelity Total Market Index Fund | 143.66K | 0.16% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CGTX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| BIOS Fund II QP, LP | Award | 25.00K | — |
| Khattar Jack A. | Award | 25.00K | — |
| Monia Brett P | Award | 25.00K | — |
| Wallace Peggy | Award | 25.00K | — |
| RICHSTONE ELLEN B | Award | 25.00K | — |
| Doyle John Brendan | Tax withholding | 8.57K | $10.97K |
Short interest
Settled Sep 30, 2026
- Shares short
- 7.58M
- Days to cover
- 16.63
- % of shares outstanding
- 8.47%
- Average daily volume
- 455.66K
- Change since last report
- −2.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.